Molecular characterization of epidemic multiresistant Staphylococcus haemolyticus isolates. [electronic resource]
- Diagnostic microbiology and infectious disease Nov 1998
- 177-83 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0732-8893
10.1016/s0732-8893(98)00118-7 doi
Ampicillin--pharmacology Anti-Bacterial Agents--pharmacology Cefazolin--pharmacology Cefmetazole--pharmacology Cross Infection--epidemiology DNA Restriction Enzymes Drug Resistance, Microbial--genetics Drug Resistance, Multiple--genetics Electrophoresis, Gel, Pulsed-Field Gentamicins--pharmacology Hospital Bed Capacity, 500 and over Humans Imipenem--pharmacology Infant, Newborn Microbial Sensitivity Tests Neonatal Nursing Nursing Staff, Hospital Ofloxacin--pharmacology Oxacillin--pharmacology Phylogeny Staphylococcal Infections--epidemiology Staphylococcus--classification Tobramycin--pharmacology Vancomycin--pharmacology